Prognostic impact of miR-17-5p and miR-20a-5p in NSCLC diverge in subgroups according to lymph node status.

Saved in:
Bibliographic Details
Title: Prognostic impact of miR-17-5p and miR-20a-5p in NSCLC diverge in subgroups according to lymph node status.
Authors: Førde D; Translational Cancer Research Group, Institute of Clinical Medicine, UiT The Arctic University of Norway, Tromsø, Norway., Kilvær T; Translational Cancer Research Group, Institute of Clinical Medicine, UiT The Arctic University of Norway, Tromsø, Norway.; Department of Oncology, University Hospital of North Norway, Tromsø, Norway., Pedersen MI; Translational Cancer Research Group, Institute of Clinical Medicine, UiT The Arctic University of Norway, Tromsø, Norway., Lombardi AP; Translational Cancer Research Group, Institute of Medical Biology, UiT The Arctic University of Norway, Tromsø, Norway., D'arsiè I; Cellular, Computational and Integrative Biology, University of Trento, Trento, Italy., Paulsen EE; Translational Cancer Research Group, Institute of Clinical Medicine, UiT The Arctic University of Norway, Tromsø, Norway.; Department of Oncology, University Hospital of North Norway, Tromsø, Norway., Busund LR; Translational Cancer Research Group, Institute of Medical Biology, UiT The Arctic University of Norway, Tromsø, Norway.; Department of Clinical Pathology, University Hospital of North Norway, Tromsø, Norway., Rakaee M; Translational Cancer Research Group, Institute of Medical Biology, UiT The Arctic University of Norway, Tromsø, Norway.; Department of Clinical Pathology, University Hospital of North Norway, Tromsø, Norway.; Department of Cancer Genetics, Oslo University Hospital, Oslo, Norway., Dønnem T; Translational Cancer Research Group, Institute of Clinical Medicine, UiT The Arctic University of Norway, Tromsø, Norway.; Department of Oncology, University Hospital of North Norway, Tromsø, Norway., Andersen S; Translational Cancer Research Group, Institute of Clinical Medicine, UiT The Arctic University of Norway, Tromsø, Norway.; Department of Oncology, University Hospital of North Norway, Tromsø, Norway.
Source: Frontiers in oncology [Front Oncol] 2025 Sep 25; Vol. 15, pp. 1606933. Date of Electronic Publication: 2025 Sep 25 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41079079
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Prognostic impact of miR-17-5p and miR-20a-5p in NSCLC diverge in subgroups according to lymph node status.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Førde+D%22">Førde D</searchLink>; Translational Cancer Research Group, Institute of Clinical Medicine, UiT The Arctic University of Norway, Tromsø, Norway.<br /><searchLink fieldCode="AU" term="%22Kilvær+T%22">Kilvær T</searchLink>; Translational Cancer Research Group, Institute of Clinical Medicine, UiT The Arctic University of Norway, Tromsø, Norway.; Department of Oncology, University Hospital of North Norway, Tromsø, Norway.<br /><searchLink fieldCode="AU" term="%22Pedersen+MI%22">Pedersen MI</searchLink>; Translational Cancer Research Group, Institute of Clinical Medicine, UiT The Arctic University of Norway, Tromsø, Norway.<br /><searchLink fieldCode="AU" term="%22Lombardi+AP%22">Lombardi AP</searchLink>; Translational Cancer Research Group, Institute of Medical Biology, UiT The Arctic University of Norway, Tromsø, Norway.<br /><searchLink fieldCode="AU" term="%22D'arsiè+I%22">D'arsiè I</searchLink>; Cellular, Computational and Integrative Biology, University of Trento, Trento, Italy.<br /><searchLink fieldCode="AU" term="%22Paulsen+EE%22">Paulsen EE</searchLink>; Translational Cancer Research Group, Institute of Clinical Medicine, UiT The Arctic University of Norway, Tromsø, Norway.; Department of Oncology, University Hospital of North Norway, Tromsø, Norway.<br /><searchLink fieldCode="AU" term="%22Busund+LR%22">Busund LR</searchLink>; Translational Cancer Research Group, Institute of Medical Biology, UiT The Arctic University of Norway, Tromsø, Norway.; Department of Clinical Pathology, University Hospital of North Norway, Tromsø, Norway.<br /><searchLink fieldCode="AU" term="%22Rakaee+M%22">Rakaee M</searchLink>; Translational Cancer Research Group, Institute of Medical Biology, UiT The Arctic University of Norway, Tromsø, Norway.; Department of Clinical Pathology, University Hospital of North Norway, Tromsø, Norway.; Department of Cancer Genetics, Oslo University Hospital, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Dønnem+T%22">Dønnem T</searchLink>; Translational Cancer Research Group, Institute of Clinical Medicine, UiT The Arctic University of Norway, Tromsø, Norway.; Department of Oncology, University Hospital of North Norway, Tromsø, Norway.<br /><searchLink fieldCode="AU" term="%22Andersen+S%22">Andersen S</searchLink>; Translational Cancer Research Group, Institute of Clinical Medicine, UiT The Arctic University of Norway, Tromsø, Norway.; Department of Oncology, University Hospital of North Norway, Tromsø, Norway.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101568867%22">Frontiers in oncology</searchLink> [Front Oncol] 2025 Sep 25; Vol. 15, pp. 1606933. <i>Date of Electronic Publication: </i>2025 Sep 25 (<i>Print Publication: </i>2025).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101568867 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2234-943X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222234943X%22">2234943X </searchLink><i>NLM ISO Abbreviation: </i>Front Oncol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41079079
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fonc.2025.1606933
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1606933
    Titles:
      – TitleFull: Prognostic impact of miR-17-5p and miR-20a-5p in NSCLC diverge in subgroups according to lymph node status.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Førde D
      – PersonEntity:
          Name:
            NameFull: Kilvær T
      – PersonEntity:
          Name:
            NameFull: Pedersen MI
      – PersonEntity:
          Name:
            NameFull: Lombardi AP
      – PersonEntity:
          Name:
            NameFull: D'arsiè I
      – PersonEntity:
          Name:
            NameFull: Paulsen EE
      – PersonEntity:
          Name:
            NameFull: Busund LR
      – PersonEntity:
          Name:
            NameFull: Rakaee M
      – PersonEntity:
          Name:
            NameFull: Dønnem T
      – PersonEntity:
          Name:
            NameFull: Andersen S
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 25
              M: 09
              Text: 2025 Sep 25
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 2234-943X
          Numbering:
            – Type: volume
              Value: 15
          Titles:
            – TitleFull: Frontiers in oncology
              Type: main
ResultId 1